Revenue Update on Qiagen NV(NASDAQ:QGEN)

Qiagen NV(NASDAQ:QGEN) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Jul 28, 2016. Company reported revenue of $334.40M. Analysts estimated a revenue of $326.73M. Earnings per share were $0.24. Analysts had estimated an EPS of $0.23.

Qiagen NV (QGEN) made into the market gainers list on Thursdays trading session with the shares advancing 0.08% or 0.02 points. Due to strong positive momentum, the stock ended at $26.61, which is also near the day’s high of $26.709. The stock began the session at $26.61 and the volume stood at 6,50,640 shares. The 52-week high of the shares is $28.53 and the 52 week low is $19.94. The company has a current market capitalization of $6,227 M and it has 23,40,00,000 shares in outstanding.

QIAGEN N.V. (QIAGEN) is a Netherlands-based holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies bioinformatics and automation systems. Sample to Insight molecular technologies are applicable across a range of applications and customer classes through more than 500 core consumable products as well as instruments that automate the use of these products for sample preparation analysis and interpretation. The Company’s bioinformatics solutions connect laboratory workflows and process amounts of genomic data enabling scientists or clinicians to interpret results and decide on further action.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Qiagen NV - Is it time to Sell?

Top Brokerage Firms are advising their investors on Qiagen NV. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.